The use of intraperitoneal chemotherapy for advanced ovarian cancer - The experience of a tertiary referral centre.

Leon Foster Christina Girgis Adrienne Kirby Paul Harnett Alison H Brand

Published in: The Australian & New Zealand journal of obstetrics & gynaecology (2023)

Our cohort had a high rate of completion of IP chemotherapy with excellent rates of completion of six cycles of any treatment. The RFS and OS in the IP chemotherapy group were comparable to each other and reflected those in the published literature. A significantly higher proportion of patients in the IP cohort were alive at ten years than in the IV cohort.

Keyphrases

locally advanced
end stage renal disease
ejection fraction
systematic review
newly diagnosed
chronic kidney disease
primary care
peritoneal dialysis
prognostic factors
squamous cell carcinoma
patient reported outcomes
randomized controlled trial
chemotherapy induced
smoking cessation